SARS-CoV-2 Attacks Kidney Proximal Tubular Cells Causing Acute Fanconi Syndrome According To French Study
Source: SARS-CoV-2 Jun 09, 2020 4 years, 6 months, 1 week, 6 days, 4 hours, 36 minutes ago
SARS-CoV-2-associated acute kidney injury (AKI) is one of the more frequently encountered organ involvements in COVID-19, occurring in as many as 80% of all critically ill patients. A new French study shows that the SARS-CoV-2 coronavirus that causes the deadly COVID-19 disease, also attacks the proximal tubular cells of the kidney and causes the development of acute Fanconi syndrome as one of the many types of kidney injury associated with COVID-19.
.jpg)
The main hallmark of the syndrome is increased excretion or loss of certain substances (such as protein, phosphate or glucose) in urine. This renal dysfunction often precedes acute kidney injury and disappears again when the kidneys recover.
The study findings of the research conducted by the medical team from University of Lorraine-France are published in the Clinical Kidney Journal.
https://academic.oup.com/ckj/advance-article/doi/10.1093/ckj/sfaa109/5854455
It was found that the SARS-CoV-2 coronavirus infects the cells of the renal tubule system (proximal tubule cells), inter alia, because tubular cells express the ACE2 cell surface receptor that SARS-CoV-2 uses to invade host cells. The proximal tubular cells normally ensure (by reabsorption into blood) that important substances are not excreted in urine and are thus lost to the body (e.g., glucose, bicarbonate, potassium, phosphate, amino acids/proteins).
Typically proximal tubule injury causes renal Fanconi syndrome, a disease in which said substances are lost in urine. The consequences or symptoms are disorders of mineral balance, accompanied by a reduction in bone density due to phosphate loss, bone pain, hyperacidity of the blood (acidosis, i.e., lowered pH), frequent urination (polyuria), dehydration, increased thirst, physical weakness (loss of cellular energy due to phosphate deficiency).
The research investigated the hypothesis that, depending on the severity of SARS-CoV-2 infection, Fanconi syndrome might occur as an indication of renal tubule involvement.
Medical data from 42 hospitalized COVID-19 patients (all with positive throat swab) who had no previous kidney disease were analyzed retrospectively. The mean follow-up was 19.7 (±12) days. It was found that a total of 75% of the patients had (incomplete) Fanconi syndrome (at least two tubular abnormalities).
Interestingly, the most frequently presented features were proteinuria (88%, n=35), phosphate loss in urine (55%, n=22), increased uric acid excretion (43%, n=17) and glycosuria (30%, n=12). Intensive care patients were more frequently affected (96% vs. 62%) and were also more severely affected by proteinuria (protein in urine 844±43 vs. 350±221 mg/g) and by AKI.
A significant finding was that Fanconi syndrome preceded severe AKI in 7/8 (88%) of the patients. Five of the AKI patients required dialysis; two died (after 13 and 27 days); one patient was dialysis-free after one week and two patients were still on dialysis at the end of the follow-up. A total of 7/42 patients died (including six intensive care patients with AKI), 24/42 could be discharged (including 12 intensive care patients) and 11/42 patients were treated as in-patients for a further 34 (±4.3) days. Clinical improvement of patients was a
lso accompanied by a reversal of renal Fanconi symptom.
Dr Raphaël Kormann, a Professor from the Department of Nephrology, University of Lorraine and lead author told Thailand Medical News, "The proximal renal tubules seem to be a specific target of SARS-CoV-2 because of their ACE2 receptors, and we see verification of our hypothesis that this is the cause of the tubular disorders and AKI that so many of our COVID-19 patients have developed.’
He further added, "Although by no means all COVID-19 patients with Fanconi syndrome developed AKI, we believe that the four markers (increased urinary excretion of protein, phosphate, uric acid and glucose), if a new occurrence, indicate specific proximal-tubular injury from which AKI can develop. This should be subjected to further systematic investigation with regard to the significance of Fanconi syndrome as a biomarker of tubular cell infection and as a potential predictive prognostic marker."
Professor Alberto Ortiz, Editor-in-Chief of the Clinical Kidney Journal commented, "It must also be assumed that there is an increased risk of subsequent kidney disease after SARS-CoV-2-associated Fanconi syndrome, as is also the case after acute kidney injury. For that reason, patients should always be followed-up nephrologically so that associated conditions are detected in time."
For more the latest on
SARS-CoV-2 coronavirus research, keep on logging to Thailand Medical News.
